Dermaliq
Wilmington, US · 1 known investors
Dermaliq Therapeutics is a specialty pharmaceutical company developing topical dermatology therapies and medical skin care products based on its proprietary hyliQ drug-delivery platform, with a lead pipeline focused on hair loss conditions such as androgenetic alopecia and alopecia areata. Its candidates target delivery of active molecules into hair follicles and skin for patients with pattern hair loss, immune-mediated hair loss, and wound healing.
Founders & leadership
OS
Oliver SchlüterCFO & Co-Founder
BH
Betsy Hughes-FormellaCSO & Co-Founder / R&D Consultant
CR
Christian RoeskyCEO & President
Investors · 1
Frequently asked questions
- What does Dermaliq do?
- Dermaliq Therapeutics is a specialty pharmaceutical company developing topical dermatology therapies and medical skin care products based on its proprietary hyliQ drug-delivery platform, with a lead pipeline focused on hair loss conditions such as androgenetic alopecia and alopecia areata. Its candidates target delivery of active molecules into hair follicles and skin for patients with pattern hair loss, immune-mediated hair loss, and wound healing.
- Who founded Dermaliq?
- Dermaliq was founded by Oliver Schlüter, Betsy Hughes-Formella.
- Who are Dermaliq's investors?
- Dermaliq's investors include 3E Bioventures Capital.
- Where is Dermaliq headquartered?
- Dermaliq is headquartered in Wilmington, US.